(Q82906878)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21161528%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

title

Phase 1 study of conatumumab, a pro-apoptotic death receptor 5 agonist antibody, in Japanese patients with advanced solid tumors (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21161528%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

1 reference

T Doi

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21161528%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

H Murakami

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21161528%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

A Ohtsu

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21161528%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

N Fuse

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21161528%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

T Yoshino

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21161528%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

N Yamamoto

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21161528%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

N Boku

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21161528%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

Y Onozawa

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21161528%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

C-P Hsu

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21161528%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

K S Gorski

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21161528%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

G Friberg

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21161528%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

T Kawaguchi

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21161528%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

T Sasaki

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21161528%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

publication date

16 December 2010

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21161528%20AND%20SRC:MED&resulttype=core&format=json

Cancer Chemotherapy and Pharmacology

18 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21161528%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

volume

68

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21161528%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21161528%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

page(s)

733-741

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21161528%20AND%20SRC:MED&resulttype=core&format=json